IP Library › Granted Patent US 11,827,796
Granted Patent B2
US 11,827,796 · App. 16/378,779 · Granted Nov 28, 2023

Curable resin composition for three-dimensional shaping and method of manufacturing three-dimensionally shaped product

Inventor: Chiaki Nishiura (Tokyo, JP)
Assignee: CANON KABUSHIKI KAISHA
C09D11/107B29C64/124B33Y10/00B33Y70/00C09D11/101
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,827,796
App. No.
16/378,779
Granted
Nov 28, 2023
Kind
B2
Abstract

Provided is a curable resin composition including (A) a (meth)acrylic compound having a number-average molecular weight of 5,000 or less and represented by the formula (1) (R 1 is a hydrogen atom, etc., L 1 and L 2 each represent an alkylene group, etc., L 3 represents a divalent linking group having an ether structure, etc. and Q 1 to Q 3 each represent a divalent linking group —O—, etc.), (B) a (meth)acrylic organosiloxane compound having a number-average molecular weight of 1,000 or less and represented by the following formula (2) (R 3 represents a hydrogen atom, etc., R 4 represents an alkyl group, etc., L 4 represents a single bond, etc., Q 4 represents a single bond, etc., and m stands for an average number of repeating constituting units) and (C) a curing agent. A (meth)acrylic compound (A):(meth)acrylic organosiloxane compound (B) mass ratio is 40:60 to 85:15.

Claims (42)

1. A curable resin composition for three-dimensional shaping, comprising:

(A) a (meth)acrylic compound having a number-average molecular weight of 5,000 or less and represented by formula (1):

wherein, in the formula (1):

R 1 represents a hydrogen atom or a methyl group;

L 1 and L 2 each represent a substituted or unsubstituted linear or cyclic alkylene group having from 1 to 20 carbon atoms or a substituted or unsubstituted arylene group having from 1 to 20 carbon atoms and the carbon atom(s) constituting the alkylene group or arylene group may be substituted with an oxygen atom, a sulfur atom, a nitrogen atom or a silicon atom;

L 3 is a linear or cyclic divalent linking group containing an ether structure, an ester structure or a carbonate structure;

Q 1 , Q 2 and Q 3 each represent a divalent linking group —O— or —NR 2 —, where R 2 represents a hydrogen atom or a substituted or unsubstituted linear or cyclic alkyl group having from 1 to 10 carbon atoms;

(B) a (meth)acrylic organosiloxane compound having a number-average molecular weight of 1,000 or less and represented by formula (2):

wherein, in the formula (2):

R 3 represents a hydrogen atom or a methyl group;

each R 4 represents an alkyl group having from 1 to 6 carbon atoms or a phenyl group and respective R 4 s in different repeating constituting units may be different from each other;

L 4 represents a single bond or a substituted or unsubstituted linear or cyclic alkylene group having from 1 to 10 carbon atoms and the carbon atom(s) constituting the alkylene group may be substituted with an oxygen atom, a sulfur atom, a nitrogen atom or a silicon atom;

Q 4 represents a single bond or a divalent linking group —O—; and

m represents an average of the number of the repeating constituting units and is a value at which the number-average molecular weight of the (meth)acrylic organosiloxane compound becomes 1,000 or less;

(C) a curing agent; and

(D) a reactive diluent,

wherein:

supposing that a total mass of the (meth)acrylic compound (A) and the (meth)acrylic organosiloxane compound (B) is 100, a (meth)acrylic compound (A) :

(meth)acrylic organosiloxane compound (B) mass ratio is from 40:60 to 85:15;

a total content of the (meth)acrylic compound (A) and the (meth)acrylic organosiloxane compound (B) is 75 parts by mass to 100 parts by mass when a mass of the curable resin composition, excluding a mass of the curing agent (C), is 100 parts by mass; and

a content of the reactive diluent (D) is 10 parts by mass to 75 parts by mass based on 100 parts by mass of the total mass of the (meth)acrylic compound (A) and the (meth)acrylic organosiloxane compound (B).

2. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the number-average molecular weight of the (meth)acrylic compound (A) is 1000 to 3200.

3. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the (meth)acrylic compound (A) has, as R 1 , a hydrogen atom.

4. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the (meth)acrylic compound (A) has, as each of Q 1 , Q 2 , and Q 3 , a divalent linking group —O—.

5. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the number-average molecular weight of the (meth)acrylic organosiloxane compound (B) is 200 to 500.

6. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the (meth)acrylic organosiloxane compound (B) has, as R 3 , a methyl group.

7. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the (meth)acrylic organosiloxane compound (B) has, as R 4 , a methyl group.

8. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the curing agent (C) is a photopolymerization initiator.

9. The curable resin composition for three-dimensional shaping according to claim 8 , wherein the photopolymerization initiator is a photoradical polymerization initiator.

10. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the reactive diluent (D) comprises a radical polymerizable monomer.

11. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the reactive diluent (D) comprises a (meth)acrylate-based monomer.

12. A method of manufacturing a three-dimensionally shaped product, comprising a step of photocuring a curable resin composition into respective layers thereof based on slice data and shaping them into the shaped product,

wherein the curable resin composition is the curable resin composition as claimed in claim 1 .

13. The method according to claim 12 , further comprising a step of exposing the shaped product to heat to obtain the three-dimensionally shaped product.

14. The curable resin composition for three-dimensional shaping according to claim 1 , wherein a viscosity of the curable resin composition at 25° C. is 70 mPa·s to 5,000 mPa·s.

15. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the content of the reactive diluent (D) is 22 parts by mass to 46 parts by mass based on 100 parts by mass based on the total mass of the (meth)acrylic compound (A) and the (meth)acrylic organosiloxane compound (B).

16. A method of manufacturing a three-dimensionally shaped product, comprising a step of photocuring a curable resin composition into respective layers thereof based on slice data and shaping them into the shaped product,

wherein the curable resin composition is the curable resin composition as claimed in claim 10 .

17. The curable resin composition for three-dimensional shaping according to claim 1 , wherein the reactive diluent (D) comprises isobornyl (meth)acrylate or isobornyl (meth)acrylate.

18. The curable resin composition for three-dimensional shaping according to claim 15 , wherein the reactive diluent (D) comprises a radical polymerizable monomer.

19. The curable resin composition for three-dimensional shaping according to claim 15 , wherein the reactive diluent (D) comprises a (meth)acrylate-based monomer.

20. The curable resin composition for three-dimensional shaping according to claim 15 , wherein the reactive diluent (D) comprises isobornyl methacrylate or isobornyl acrylate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 4, 2019
From: NISHIURA, CHIAKI
To: CANON KABUSHIKI KAISHA
Reel/Frame 049668/0505 →
Priority Claims (2)
JP 2018-078098 · Apr 16, 2018 · national
JP 2019-044363 · Mar 12, 2019 · national
Continuity (1)
Related Publication 20190315981A1 · Oct 17, 2019